Skip to content

Biomarkers for neonatal acute respiratory distress syndrome: a prospective cohort study

Discriminative study of neonatal acute respiratory distress syndrome (ARDS) and neonatal respiratory distress syndrome (NRDS) based on transcriptomics and proteomics

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400085274
Enrollment
Unknown
Registered
2024-06-04
Start date
2021-10-31
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal acute respiratory distress syndrome

Interventions

Neonatal acute respiratory distress syndrome(<34w):N/A
Neonatal acute respiratory distress syndrome(=34w):N/A
Neonatal respiratory distress syndrome:N/A

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Newborns manifested with respiratory distress within 24 hours after birth, including progressive dyspnea, groaning, three concave sign, and cyanosis; (2) newborns need non-invasive or invasive respiratory support within 24 hours after birth; (3) Imaging showed RDS manifestations, including air bronchogram, ground-glass lung lesions, white lung, etc.

Exclusion criteria

Exclusion criteria: (1) The presence of congenital malformations/developmental abnormalities affecting respiratory function, such as congenital heart disease, diaphragmatic hernia, pulmonary stenosis; (2) Genetic metabolic diseases; (3) Abnormal structure of upper respiratory tract; (4) Intubation required for surgical operations; (5) Grade III or IV intracranial hemorrhage; (6) Family members are unwilling to participate in.

Design outcomes

Primary

MeasureTime frame
proteome;transcriptome;target molecule screened by proteome or transcriptome;

Countries

China

Contacts

Public ContactShi Yuan

Children's Hospital of Chongqing Medical University

shiyuan@hospital.cqmu.edu.cn+86 135 0830 0283

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026